Certificate Course in Gynecological Cancers

Gynecologic oncology: FIGO staging, diagnostics, surgery, systemic therapy, radiation, survivorship.

What you'll learn
- Apply FIGO staging and risk stratification across cervical, endometrial, ovarian, vulvar, and vaginal cancers.
- Select guideline-aligned workup: Pap/HPV triage, endometrial sampling, imaging, and molecular tests to refine diagnosis.
- Plan first-line and adjuvant therapy—surgery, radiation, chemotherapy, targeted agents, and immunotherapy—with fertility-sparing options.
- Manage toxicities, surveillance, and recurrence; design survivorship plans using case-based, tumor-board style reasoning.

Requirements
- No strict prerequisites—beginners are welcome. A basic grasp of clinical anatomy, physiology, and medical terminology is helpful, and prior OB/GYN or internal medicine exposure is a plus but not required. You’ll need a computer with reliable internet and audio for HD streaming, and a willingness to learn guideline-based gynecologic oncology (note-taking materials recommended).

Description
Elevate your gynecologic oncology practice with a focused, guideline-based curriculum designed for ABIM-oriented clinicians, USMLE Step 2 CK learners, residents, and motivated medical students. This course translates complex evidence into clear clinical actions across cervical, endometrial, ovarian, vulvar, and vaginal cancers, as well as gestational trophoblastic disease. You’ll move from symptom recognition and first-line work-up to risk stratification, staging, treatment planning, and survivorship—mirroring the way real tumor boards think.

What sets this program apart is its relentlessly practical, exam-ready framing. Each module links presentation to pathway: indications for Pap/HPV triage and endometrial sampling; how imaging and molecular markers (e.g., BRCA, HRD, MMR/p53, HPV) refine prognosis; when to operate, irradiate, or initiate systemic therapy; and how to integrate targeted agents, PARP inhibitors, anti-angiogenics, and immunotherapy. You’ll also learn peri-operative optimization, toxicity recognition and mitigation, and post-treatment surveillance strategies that fit everyday clinic and inpatient workflows.

The format is concise, chapteredvideo lectures only(no downloadable lecture notes). Sessions are kept current with evolving international guidelines and therapeutic advances, helping you stay aligned with best practices while preparing for boards and ward-based decision making. No prior subspecialty training is required—basic clinical anatomy/physiology and medical terminology are sufficient. A reliable internet connection and a willingness to engage actively (pause, reflect, and take your own notes) will maximize your results.

Ideal for internists, hospitalists, OB/GYN and IM residents/fellows, advanced practice providers, and senior medical students, this course provides a high-yield bridge from evidence to bedside. By the end, you’ll be able to stage accurately, choose appropriate diagnostics, design first-line and adjuvant plans (surgery, radiation, chemotherapy, targeted and immune therapies), and guide survivorship with confidence—delivering safer, more consistent care to patients with gynecologic cancers.

Who this course is for:
- This course is ideal for ABIM-focused internists and hospitalists seeking a guideline-driven update in gynecologic oncology; USMLE Step 2 CK learners who want high-yield, clinically applied content; OB/GYN and internal-medicine residents/fellows building treatment-planning confidence; practicing physicians and advanced practice providers (NP/PA) who manage women’s cancer care or survivorship; and senior medical students preparing for oncology or OB/GYN rotations. It’s also valuable for primary-care clinicians with a women’s health focus who want clear staging, work-up, and therapy frameworks they can use immediately in clinic and tumor-board discussions.
More Info